Institutional shares held 45.6 Million
18.3K calls
10.2K puts
Total value of holdings $8.13B
$3.26M calls
$1.82M puts
Market Cap $8.36B
46,906,400 Shares Out.
Institutional ownership 97.24%
# of Institutions 564


Latest Institutional Activity in TFX

Top Purchases

Q3 2024
Citadel Advisors LLC Shares Held: 325K ($58M)
Q3 2024
Exodus Point Capital Management, LP Shares Held: 277K ($49.4M)
Q3 2024
Morgan Stanley Shares Held: 3.24M ($577M)
Q3 2024
Janus Henderson Group PLC Shares Held: 5.38M ($958M)
Q3 2024
Magnetar Financial LLC Shares Held: 205K ($36.6M)

Top Sells

Q3 2024
Wellington Management Group LLP Shares Held: 157K ($28M)
Q3 2024
Balyasny Asset Management LLC Shares Held: 23K ($4.09M)
Q3 2024
Millennium Management LLC Shares Held: 744K ($133M)
Q3 2024
Deka Bank Deutsche Girozentrale Shares Held: 7.37K ($1.31M)
Q3 2024
National Bank Of Canada Shares Held: 24K ($4.28M)

About TFX

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.


Insider Transactions at TFX

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
70.1K Shares
From 21 Insiders
Grant, award, or other acquisition 23.5K shares
Exercise of conversion of derivative security 40.9K shares
Bona fide gift 5.79K shares
Sell / Disposition
47.9K Shares
From 12 Insiders
Open market or private sale 36.3K shares
Payment of exercise price or tax liability 5.76K shares
Bona fide gift 5.79K shares

Track Institutional and Insider Activities on TFX

Follow TELEFLEX INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TFX shares.

Notify only if

Insider Trading

Get notified when an Teleflex Inc insider buys or sells TFX shares.

Notify only if

News

Receive news related to TELEFLEX INC

Track Activities on TFX